WuXi Biologics Posts Strong 2024 Results, Forecasts Rapid Growth in 2025
March 25, 2025 | 17:30
WuXi Biologics (Cayman) Inc., a leading global Contract Research, Development and Manufacturing Organization service company offering end-to-end solutions for biologics discovery, development and manufacturing, is pleased to announce its audited annual results for the year ended December 31, 2024.
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year
March 21, 2025 | 07:30
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by the environmental non-profit CDP for leadership in corporate transparency and performance on water security.
WuXi Biologics receives ESG Corporate Platinum Award from The Asset for fourth consecutive year
October 16, 2024 | 19:00
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization, today announced that it has received a Platinum Award from The Asset ESG Corporate Awards for the fourth year in a row.
Latest News
Mobile Version